InsiderClue
Stocks · Consumer staples · Retail-Drug Stores and Proprietary Stores

Guardian Pharmacy Services, Inc.

GRDN Clue Score74
United States Fiscal year ends December CIK 0001802255
$41.28 -0.77% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $41.28 +74.32% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 26 Sep 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2024Revenue1,228.4Operating income−62.9Net income−110.0Fiscal year 2025Revenue1,448.7 +17.9%Operating income72.7Net income49.2
FY2024FY2025
Revenue 1,228.4 1,448.7
Growth +17.9%
Operating income −62.9 72.7
Net income −110.0 49.2
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2024Gross margin19.9%Operating margin−5.1%Net margin−9.0%Free cash flow margin3.5%Fiscal year 2025Gross margin20.2%Operating margin5.0%Net margin3.4%Free cash flow margin6.0%
FY2024FY2025
Gross margin 19.9% 20.2%
Operating margin −5.1% 5.0%
Net margin −9.0% 3.4%
Free cash flow margin 3.5% 6.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2024Operating cash flow58.0Capital expenditure−14.7Free cash flow43.3Fiscal year 2025Operating cash flow100.3Capital expenditure−13.4Free cash flow86.8 +100.8%
FY2024FY2025
Operating cash flow 58.0 100.3
Capital expenditure −14.7 −13.4
Free cash flow 43.3 86.8
Growth +100.8%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2024Cash4.7Total debt0.0Net cash (debt)4.7Shareholders’ equity150.0Debt to equity0.00Fiscal year 2025Cash65.6Total debt0.0Net cash (debt)65.6Shareholders’ equity217.9Debt to equity0.00
FY2024FY2025
Cash 4.7 65.6
Total debt 0.0 0.0
Net cash (debt) 4.7 65.6
Shareholders’ equity 150.0 217.9
Debt to equity 0.00 0.00

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
58.0 100.3
Growth +73.0%
19.8 22.3
Investment
−14.7 −13.4
calc 43.3 86.8
Growth +100.8%
−30.4 −32.2
Financing
−23.6 −7.1

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.